Hertin Und Partner Rechts competitive analysis

Explore patent oppositions filed by Hertin Und Partner Rechts against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
Three-Dimensional PrinterMARKApr 1, 2025
Crush-Resistant Tablets Intended For Preventing Accidental Misuse And Unlawful DiversionETHYPHARMJul 25, 2024
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type XiiBECTON DICKINSON INFUSION THERAPY SYSTEMSApr 29, 2021
Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type XiiiBECTON DICKINSON INFUSION THERAPY SYSTEMSApr 29, 2021
Manufacturing Of Active-Free Granules And Tablets Comprising The SameEURO CELTIQUEApr 12, 2018

Latest PTAB cases involving Hertin Und Partner Rechts

Discover the latest PTAB cases involving Hertin Und Partner Rechts, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hertin Und Partner Rechts with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HERTIN UND PARTNER RECHTS5 - - -
BECTON DICKINSON INFUSION THERAPY SYSTEMS - 8 - -
ETHYPHARM112 - -
GENEOHM SCIENCES - 8 - -